Exagen Inc. (XGN): Total Assets
$58.02M
As of 2025-12-31
$51.94M
As of 2026-06-30
-12.4%
3-year compound annual growth
-5.8%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.02M | +29.8% | 2026-03-10, Balance as of period end |
| 2024-12-31 | $44.69M | -21.5% | 2026-03-10, Balance as of period end |
| 2023-12-31 | $56.94M | -34.0% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $86.22M | -30.2% | 2024-03-18, Balance as of period end |
| 2021-12-31 | $123.44M | +57.5% | 2023-03-20, Balance as of period end |
| 2020-12-31 | $78.38M | -11.3% | 2022-03-22, Balance as of period end |
| 2019-12-31 | $88.31M | +205.7% | 2021-03-16, Balance as of period end |
| 2018-12-31 | $28.89M | n/a | 2020-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Exagen Inc. (XGN) | 2025-12-31 | $58.02M | +29.8% |
| Personalis, Inc. (PSNL) | 2025-12-31 | $334.16M | +23.6% |
| Biodesix Inc (BDSX) | 2025-12-31 | $87.48M | -10.0% |
| CapForce Inc. (CFOR) | 2025-12-31 | $38.06M | +285.8% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $2.92B | -2.1% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $55.48M | -7.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $632.65M | +109.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $1.21B | -0.5% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $578.56M | +8.9% |
Compare XGN, PSNL, BDSX, CFOR side by side · Screen every company in Services-Medical Laboratories ↗